Literature DB >> 27107037

ECMO cannulation strategy for pulmonary hypertension: an alternative approach to traditional Veno-Arterial ECMO.

Allison Weinberg1, Linda Mongero2, Bethany Armstrong2.   

Abstract

Pulmonary arterial hypertension (PAH) is a severe disease characterized by a progressive increase of pulmonary pressure and resistance, leading to right heart failure. PAH is commonly diagnosed at a late stage of the disease and is associated with progressive clinical deterioration and premature death. The treatment of PAH continues to be complicated, especially when considering treatment with extracorporeal membrane oxygenation (ECMO). A case is described that involves a heart failure patient placed on a ventricular assist device as a bridge to heart transplantation with recent onset of PAH. The goal was to rest the entire pulmonary circulation during ECMO while allowing the ventricular assist device to continue to function using a modified veno-arterial (VA) cannulation strategy. This configuration allowed the patient's right heart to rest and ultimately recover while the left ventricular assist device (LVAD) maintained systemic perfusion, successfully allowing the patient to maintain a United Network for Organ Sharing (UNOS) status 1a listing.
© The Author(s) 2016.

Entities:  

Keywords:  ECMO; ECMO cannulation; cannulation strategies; extracorporeal membrane oxygenation; pulmonary artery hypertension

Mesh:

Year:  2016        PMID: 27107037     DOI: 10.1177/0267659116646179

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  2 in total

Review 1.  Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant: Considerations for Critical Care Nursing Practice.

Authors:  Brittany Koons; Jennifer Siebert
Journal:  Crit Care Nurse       Date:  2020-06-01       Impact factor: 1.708

2.  Commentary: No one-size-fits-all approach to extracorporeal membrane oxygenation.

Authors:  Justin H Berger; Katsuhide Maeda
Journal:  JTCVS Tech       Date:  2021-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.